Tocris Bioscience Intelligence Profile

tocris.comLast reviewed: October 20, 2026Research coverage: 94%

Overall data confidence:Unknown

Identity confidence

High

8 of 10 identity fields independently documented

Corporate continuity

Continuity supported — domain registered 1997-02-04; brand founded 1982 (UK), trading as Tocris Bioscience since 2005, combined with R&D Systems / acquired by Techne (now Bio-Techne) in 2011; site live today with a current catalog, and the homepage now cross-lists Tocris products on the R&D Systems website.

Based on domain history and corporate record fields

Regulatory exposure

None identified

Derived from published risk flags

Evidence integrity

High

7 of 7 testing fields documented

Transaction transparency

High

5 of 5 commercial fields documented

Change activity

None tracked

0 change events tracked

Research Incomplete

Research coverage for this vendor is 94%. Our research on Tocris Bioscience remains incomplete — what we have verified so far is published below, and research is continuing.

Still to research:

Public summary reviewed

Overview#

Tocris Bioscience is the small-molecule and research-peptide brand of Bio-Techne Corporation (Minnesota corporation, NASDAQ: TECH, HQ 614 McKinley Place NE, Minneapolis, MN 55413), headquartered operationally at its ISO 9001:2015 Bristol, UK manufacturing/QC site. FIT: confirmed — tocris.com sells a large catalog of research peptides (a dedicated Peptides product-type taxonomy spanning dozens of receptor/biology families, e.g. Melittin, Colivelin, Gap 26, Sauvagine) and small molecules direct to research buyers, all for laboratory research use only. Identity transparency is high at the parent level (SEC registrant, named CEO/CFO/Chairman, published HQ and registered office) but brand-level: Tocris itself is not a separate U.S. legal entity, no registered agent or U.S. formation date was sourced (both recorded Unknown), and principals are parent officers, not Tocris-specific managers. All defined regulatory searches (FDA warning letters, recalls, import alerts, FTC enforcement, state AG, civil litigation, criminal/injunctive) returned No Record Found in the defined search; the parent 10-K reports no material legal proceedings, and the 2026 FTC item in the news is merger review of the proposed Merck acquisition of the parent, not enforcement. Testing disclosure is strong and structurally different from RUO storefronts: QC is in-house (no independent lab named), with batch-specific CoAs retrievable by lot/batch number on each product page, custom per-compound HPLC, chiral analysis and per-batch solubility testing. Commercial terms are institutional: net-30 invoicing, FCA shipment at buyer's freight cost, returns only with authorization within 10 business days (custom orders non-returnable). No serious (High/Critical) findings; no impersonation signs — the tocris.com domain dates to 1997 and the R&D Systems cross-listing is the brand owner's own dual storefront.

Company Identity#

Vendor Brand NameTocris Bioscience

HighSource: Tocris Bioscience homepage

Primary Website Domaintocris.com

ModerateSource: Tocris Bioscience — official website (intake domain confirmation)

Legal Entity NameBio-Techne Corporation

ModerateSource: Bio-Techne Terms and Conditions (Protein Sciences segment, applied to Tocris sales)

State of RegistrationMinnesota

HighSource: Bio-Techne Corporation Form 10-K filed 2025-08-22 (SEC registrant: Minnesota, 614 McKinley Place N.E., Minneapolis, MN 55413; Item 3 Legal Proceedings; signatures)

Entity StatusActive — current SEC registrant (NASDAQ: TECH), filing Form 10-K through fiscal 2025 (filed 2025-08-22) and fiscal 2026

ModerateSource: Bio-Techne Corporation Form 10-K filed 2025-08-22 (SEC registrant: Minnesota, 614 McKinley Place N.E., Minneapolis, MN 55413; Item 3 Legal Proceedings; signatures)

Incorporation / Formation DateNot independently verified

UnknownSource: Tocris History — tocris.com

Named Principals / ManagersParent-level (Bio-Techne Corporation): Kim Kelderman, President and Chief Executive Officer; James Hippel, Chief Financial Officer; Robert V. Baumgartner, Chairman of the Board — per Form 10-K signatures, 2025-08-22. No Tocris-brand-specific manager is named on tocris.com.

ModerateSource: Bio-Techne Corporation Form 10-K filed 2025-08-22 (SEC registrant: Minnesota, 614 McKinley Place N.E., Minneapolis, MN 55413; Item 3 Legal Proceedings; signatures)

Registered AgentNot independently verified

UnknownSource: SEC EDGAR — Bio-Techne PRE 14A Appendix B, Proposed Amended Articles: name Bio-Techne Corporation; registered office 614 McKinley Place N.E., Minneapolis, MN 55413

Operating AddressTocris manufacturing/QC site: The Watkins Building, Bristol, UK (Avonbridge / Avonmouth, Bristol). U.S. ordering/contact address published on Tocris/Bio-Techne product documents: 614 McKinley Place NE, Minneapolis, MN 55413, USA

ModerateSource: Tocris History — tocris.com

Address ConsistencyConsistent — the Minneapolis address 614 McKinley Place NE, Minneapolis, MN 55413 recurs identically in SEC filings, the Articles of Incorporation, and Bio-Techne/Tocris product-document contact blocks; the Bristol, UK Tocris site is consistently described across the Tocris history page and the parent 10-K property list.

ModerateSource: Bio-Techne Corporation Form 10-K filed 2025-08-22 (SEC registrant: Minnesota, 614 McKinley Place N.E., Minneapolis, MN 55413; Item 3 Legal Proceedings; signatures)

Domain and Digital Identity#

Domain Registration Date1997-02-04

HighSource: Verisign RDAP — tocris.com

Domain Ownership / Registrar Change HistoryPartially known — current registrar GoDaddy.com, LLC; RDAP record last changed 2026-02-06. Earlier registrar/ownership history not established in this pass; registrant identity is not disclosed in RDAP.

LowSource: Verisign RDAP — tocris.com

Website ContinuityContinuity supported — domain registered 1997-02-04; brand founded 1982 (UK), trading as Tocris Bioscience since 2005, combined with R&D Systems / acquired by Techne (now Bio-Techne) in 2011; site live today with a current catalog, and the homepage now cross-lists Tocris products on the R&D Systems website.

ModerateSource: Verisign RDAP — tocris.com

Contact Channel IntegrityConsistent published channels on Tocris/Bio-Techne product documents and site: TEL 612 379 2956, Toll-free 800 343 7475, FAX 612 656 4400, Minneapolis contact address 614 McKinley Place NE; site offers Chat / Contact Us support. No conflicting phone, email, or address for Tocris was found.

ModerateSource: Tocris peptide product page via Bio-Techne — Melittin (1193): batch-specific CoA download, contact 614 McKinley Place NE, Minneapolis, MN 55413

Regulatory and Legal History#

FDA Warning Letter HistoryNo Record Found in the defined search

HighSource: Defined web search of fda.gov warning letters — no letter naming Tocris Bioscience / Bio-Techne

FDA Recall / Safety Action HistoryNo Record Found in the defined search

ModerateSource: Defined web search — Tocris / Bio-Techne FDA recall

FDA Import Alert / Detention ExposureNo Record Found in the defined search

ModerateSource: Defined web search — Tocris FDA import alert / detained

FTC Enforcement HistoryNo Record Found in the defined search

HighSource: Defined web search of ftc.gov — no action naming Tocris Bioscience / Bio-Techne

State Regulatory / Attorney General ActionsNo Record Found in the defined search

ModerateSource: Defined web search — Tocris / Bio-Techne attorney general / state regulator

Relevant Civil LitigationNo Record Found in the defined search

ModerateSource: Bio-Techne Corporation Form 10-K filed 2025-08-22 (SEC registrant: Minnesota, 614 McKinley Place N.E., Minneapolis, MN 55413; Item 3 Legal Proceedings; signatures)

Criminal / Injunctive ProceedingsNo Record Found in the defined search

ModerateSource: Defined web search — Tocris / Bio-Techne criminal / injunction / indicted

Testing and COA Evidence#

Public COA AvailabilityCOAs are publicly available per product — each Tocris product page offers a Certificate of Analysis download by lot/batch number ('To download a Certificate of Analysis, please enter a lot or batch number' / select a batch), before or without purchase. Example retrieved: CoA PDF for Cat. No. 7448, Batch No. 1, showing HPLC, chiral HPLC, 1H NMR, mass and UV data.

HighSource: Tocris Certificate of Analysis example — Cat. No. 7448, Batch No. 1 (HPLC 96.4%, chiral HPLC, NMR, MS)

Batch / Lot SpecificityEstablished — CoAs are batch-specific: each CoA is headed with the product's Catalog No. and Batch No. and reports that batch's analytical data, and product pages instruct buyers to use 'the batch-specific molecular weight of the product found on the vial label and CoA.'

HighSource: Tocris Certificate of Analysis example — Cat. No. 7448, Batch No. 1 (HPLC 96.4%, chiral HPLC, NMR, MS)

Independent Laboratory IdentityNo independent (third-party) laboratory is named — testing is performed IN-HOUSE by Tocris at Bio-Techne's ISO 9001:2015-accredited Bristol, UK site. The vendor states 'the overwhelming majority of Tocris products are subject to comprehensive QC performed in-house by experienced Analysts; a select range is sourced and checked from trusted partners' (partners not named).

HighSource: Tocris Quality / Your Supplier of Choice — tocris.com

COA Verification StatusVerifiable through the vendor's own lookup — a buyer can enter a lot/batch number on the product page and retrieve that batch's CoA; CoA content (HPLC purity, chiral HPLC, NMR/MS consistency) is reported per batch. No separate third-party lab verification portal exists, because QC is in-house (see independent_laboratory_identity).

ModerateSource: Tocris Certificate of Analysis example — Cat. No. 7448, Batch No. 1 (HPLC 96.4%, chiral HPLC, NMR, MS)

Test RecencyCurrent — batch CoAs are live for the current catalog; the example CoA retrieved in this pass (Cat. No. 7448, Batch No. 1) carries a print date of July 15, 2026. Recency is established per batch at download, not by a single catalog-wide test date.

ModerateSource: Tocris Certificate of Analysis example — Cat. No. 7448, Batch No. 1 (HPLC 96.4%, chiral HPLC, NMR, MS)

Testing CoverageVendor-stated coverage is catalog-wide and per-batch: custom HPLC purity method for every compound, solubility tested on every batch, chiral analysis where relevant with results on the CoA, individual impurity limits typically <1%, and residual-solvent, molecular-formula/weight and (for dyes) photophysical data reported at batch level, across 4,500+ Tocris reagents including its peptide range.

ModerateSource: Tocris Quality / Your Supplier of Choice — tocris.com

Evidence ConsistencyConsistent, with one framing note — purity/QC claims on the Quality page (custom HPLC per compound, >98% purity standard for custom synthesis, per-batch CoAs) match the per-batch CoA documents actually published, which report product-specific results (e.g., 96.4% HPLC for a fluorescent probe, Cat. 7448) rather than a blanket 100% claim, i.e. specs are per-product as stated. No falsified-evidence indicators found. Framing note: tocris.com now cross-sells the same Tocris products on the R&D Systems storefront — a dual-storefront presentation of one brand, not two vendors.

ModerateSource: Tocris Quality / Your Supplier of Choice — tocris.com

Payment, Refund and Shipping#

Accepted Payment MethodsInstitutional terms established; consumer-style methods not published — Bio-Techne Terms §10: payment terms are net 30 days from date of invoice, in the currency specified on the invoice, charged only for products shipped. No credit-card / PayPal / crypto list is published on the tocris.com pages fetched, and the online checkout flow was not inspected in this text-fetch pass.

ModerateSource: Bio-Techne Terms and Conditions (Protein Sciences segment, applied to Tocris sales)

Refund / Return PolicyReturns require prior authorization — Bio-Techne Terms §11: a buyer must contact Customer Service within 10 business days of receipt to request a Return Authorization for damaged/defective products; no return/credit without one; products must be returned within 30 calendar days of the authorization, in original containers with original labels, for credit of the original purchase price less any applicable Returned Products Charge (20% of returned products plus shipping for duplicate confirming orders, §5). Custom orders are ineligible for cancellation or return.

HighSource: Bio-Techne Terms and Conditions (Protein Sciences segment, applied to Tocris sales)

Shipping & Fulfillment RepresentationsBio-Techne Terms §6: shipments are FCA (Free Carrier) Bio-Techne's facility, INCOTERMS 2010; buyer pays/reimburses freight, insurance, packaging, handling, taxes and duties; Bio-Techne may select the carrier if none is specified, may ship in installments, and shipment schedules are approximate with no liability for delay. Tocris Quality page adds a service representation: over 99% of products always in stock, delivering within 1–3 business days of order. A Bio-Techne-mirrored Tocris peptide listing shows '$45 to United States' shipping.

ModerateSource: Bio-Techne Terms and Conditions (Protein Sciences segment, applied to Tocris sales)

Terms / Policy StabilityBaseline intake — the operative terms are Bio-Techne's unified Protein Sciences Standard Terms & Conditions, applied across its brands including Tocris, rather than a Tocris-only policy set; no dated revision history for those terms was located in this pass, so stability over time is not yet measurable. Future refresh cycles can diff the terms page directly.

LowSource: Bio-Techne Terms and Conditions (Protein Sciences segment, applied to Tocris sales)

Customer Complaint PatternNo Record Found in the defined search

ModerateSource: Defined searches — BBB, Trustpilot, web (no Tocris Bioscience profile or pattern found)

Material Changes#

No material changes recorded.

Sources#

SEC EDGAR — Bio-Techne PRE 14A Appendix B, Proposed Amended Articles: name Bio-Techne Corporation; registered office 614 McKinley Place N.E., Minneapolis, MN 55413Tier 1 · AuthoritativeSec FilingAuthoritative

Retrieved: October 20, 2026